Advocacy intelligence hub — real-time data for patient organizations
University of Hawaii — NA
First Hospital of China Medical University — PHASE4
UCB Biopharma SRL — PHASE3
Xijing Hospital — NA
LEO Pharma — PHASE2
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico — NA
German Federal Institute for Risk Assessment
Alberto Pilotto — NA
Massachusetts General Hospital — PHASE3
University Hospital, Toulouse — PHASE3
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Brigitte Tardy, MD
Centre Hospitalier Universitaire de Saint Etienne
Robert Bissonnette, MD
Innovaderm Research
Edward W Cowen, M.D., M.D
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
📍 SILVER SPRING, MD
Robert Bissonnette, MD MSc FRCPC
Innovaderm Research Incorporated
Antonio Martorell, PhD
Hospital Universitari de Manises
Lyn C Guenther, MD, FRCPC, MS, LPC, NCC
The Guenther Dermatology Research Centre
📍 ENGLEWOOD, CO